Upgrade to SI Premium - Free Trial

Abbvie (ABBV) Reiterated at Overweight by Cantor Fitzgerald on Zumilokibart Promise

September 16, 2026 7:41 AM
Cantor Fitzgerald analyst Carter Gould reiterated an Overweight rating on Abbvie (NYSE: ABBV).The analyst commented, "Durability and mode ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments